Concepedia

A phase I-II study of 9-cis retinoic acid and interferon-α2b in patients with advanced renal-cell carcinoma: An NCIC Clinical Trials Group study

Wilson H. Miller, Leonard Reyno, Gordon Loewen, S. Huan, Eric Winquist, Malcolm J. Moore, Andrew C.B. Cato, D. Jaunakais, J A Truglia, S. Matthews,

Annals of Oncology · 2000 · 18 citations · 5 references

DOIFull text

Open access

Concepts

References

5

13-cis-Retinoic Acid and Interferon   -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin

S. M. Lippman, David Parkinson, Loretta M. Itri et al. · JNCI Journal of the National Cancer Institute · 1992 · 396 citations

, , +10

13-cis-Retinoic Acid Plus Interferon   -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

S. M. Lippman, J. J. Kavanagh, M. Paredes-Espinoza et al. · JNCI Journal of the National Cancer Institute · 1992 · 323 citations

, , +10

Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.

Robert J. Motzer, Lawrence B. Schwartz, Teresa Murray Law et al. · Journal of Clinical Oncology · 1995 · 153 citations

, , +17

9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia

WH Jr Miller, AA Jakubowski, WP Tong et al. · Blood · 1995 · 91 citations · Full text

, , +11

Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid.

V A Miller, James R. Rigas, Francesca Benedetti et al. · PubMed · 1996 · 64 citations

, , +13